1-5 of 5
Nancy Valente
Close
Sort by
Journal Articles

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

Martin Weisser, Ru-Fang Yeh, Guillemette Duchateau-Nguyen, Giuseppe Palermo, Tri Quang Nguyen, Xiaoyan Shi, Susanna Y. Stinson, Nancy Yu, Annika Dufour, Tadeusz Robak, Galina N. Salogub, Anna Dmoszynska, Philippe Solal-Celigny, Krzysztof Warzocha, Javier Loscertales, John Catalano, Loree Larratt, Viktor A. Rossiev, Isabelle Bence-Bruckler, Christian H. Geisler, Marco Montillo, Kirsten Fischer, Anna-Maria Fink, Michael Hallek, Johannes Bloehdorn, Raymonde Busch, Axel Benner, Hartmut Döhner, Nancy Valente, Michael K. Wenger, Stephan Stilgenbauer, David Dornan
Journal: Blood
Blood (2014) 124 (3): 420–425.
https://doi.org/10.1182/blood-2013-12-538975
Published: 2014
Includes: Supplemental data
Journal Articles

Higher Doses of Rituximab May Be Required for Patients with CLL as Compared to NHL Based On Population Pharmacokinetic (PK) Modeling.

Jing Li, Ph.D., Jianguo Zhi, Ph.D., Michael K. Wenger, MD, Nancy Valente, MD, Jennifer Visich, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1742.
https://doi.org/10.1182/blood.V114.22.1742.1742
Published: 2009
Journal Articles

Evaluation of Humoral Immune Responses to Vaccination with Tetanus Toxoid and KLH in Rituximab-Treated Follicular Non-Hodgkin’s Lymphoma Patients Compared to Healthy Volunteers

M. Wayne Saville, MD, FACP, FRCPA, Nancy Valente, MD, Rachelle Perea, Kye Gilder, Judith Berlfein, Ilya Zyuzgin, PhD, David Belada, MD., PhD., Andre Banat, MD, MBA, Tudor Ciuleanu, MD
Journal: Blood
Blood (2008) 112 (11): 3066.
https://doi.org/10.1182/blood.V112.11.3066.3066
Published: 2008
Journal Articles

Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients.

Jing Li, PhD, Micha Levi, PHD, Jean-Eric Charoin, PharmD, Nicolas Frey, PharmD, Thian Kheoh, PHD, Song Ren, PHD, Michael Woo, PharmD, Amita Joshi, PHD, Nancy Valente, MD, Nelson ‘Shasha’ Jumbe, PHD, PE
Journal: Blood
Blood (2007) 110 (11): 2371.
https://doi.org/10.1182/blood.V110.11.2371.2371
Published: 2007
Journal Articles

Cost-Effectiveness of Rituximab Post CVP Induction for the Treatment of Low-Grade NHL.

John C. Hornberger, MD, MS, Carolina Reyes, PhD, Ashwini Shewade, MS, David Loecke, PhD, Nancy Valente, MD
Journal: Blood
Blood (2007) 110 (11): 4486.
https://doi.org/10.1182/blood.V110.11.4486.4486
Published: 2007